Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery

NCT01158534 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Cancer
Stage IV Renal Cell Cancer

Interventions

DRUG: celecoxib
BIOLOGICAL: recombinant interferon alfa-2b
OTHER: polymerase chain reaction
OTHER: laboratory biomarker analysis
OTHER: reverse transcriptase-polymerase chain reaction
OTHER: immunologic technique
OTHER: immunohistochemistry staining method
OTHER: flow cytometry

Sponsor

Case Comprehensive Cancer Center